AbbVie New Zealand today announced that HUMIRA® (adalimumab) is now available and funded to New Zealanders by PHARMAC to treat moderate to severe hidradenitis suppurativa (HS), a painful, debilitating, chronic skin condition
Pharmacy Technician Day (15 October 2019) is a great time to reflect on the essential role that pharmacy technicians play within the New Zealand healthcare system.
Source
Media release from the Pharmaceutical Society of New Zealand
The Pharmaceutical Society of New Zealand is calling for a formal Ministry of Health led “Catch-Up Plan” to increase the populations immunisation levels
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes